Evidence map›Paper›PMID 27547592›Full record

ArticleInternational journal of nano studies & technology

Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer.

D VanDyke, P Kyriacopulos, B Yassini, A Wright, E Burkhart, S Jacek, M Pratt, C R Peterson, P Rai

Abstract read
In one paragraph

Article in International journal of nano studies & technology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Nanotechnology-Based Dressings for Wound Management.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  8. Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.Journal of functional biomaterials · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

D VanDykeDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
P KyriacopulosBiomedical Engineering and Biotechnology Program, University of Massachusetts, Lowell, MA, USA.
B YassiniDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
A WrightDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
E BurkhartDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
S JacekDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
M PrattDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
C R PetersonDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA.
P RaiDepartment of Chemical Engineering, University of Massachusetts, Lowell, MA, USA; Biomedical Engineering and Biotechnology Program, University of Massachusetts, Lowell, MA, USA.

Funding

Theranostic Nanomedicine for Breast Cancer Prevention and Image-Guided TherapyR00CA153948 · NCI · UNIVERSITY OF MASSACHUSETTS LOWELL · PI RAI, PRAKASH R · 2012 to 2014
$704k
NCI NIH HHS R00 CA153948
6 · The paper itself

Abstract

Treatment of cancer remains one of the most challenging tasks facing the healthcare system. Cancer affects the lives of millions of people and is often fatal. Current treatment methods include surgery, chemotherapy, radiation therapies or some combinations of these. However, recurrence is a major problem. These treatments can be invasive with severe side effects. Inefficacies in treatments are a result of the complex and variable biology of cancerous cells. Malignant tumor cells and normal functioning cells share many of the same biological characteristics but the main difference is that in cancer cells there is in an overuse and over expression of these biological characteristics. These pertinent characteristics can be grouped into eight hallmarks, as illustrated by Hanahan and Weinberg. These characteristics include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, activating invasion and metastasis, reprogramming energy metabolism, and evading immune destruction. In order to provide a noninvasive, effective treatment, delivery methods must be explored in order to transport cytotoxic agents used for targeting the hallmarks of cancer in a safer and more effective fashion. The use of nanoparticles as drug delivery carriers provides an effective method in which multiple cytotoxic agents can be safely delivered to cancer tissue to simultaneously target multiple hallmarks. By targeting multiple hallmarks of cancer at once, the efficacy of cancer treatments could be improved drastically. This review explores the uses and efficacy of combination therapies using nanoparticles that can simultaneously target multiple hallmarks of cancer.

Indexed as

Combination TherapyDrug DeliveryHybrid NanoparticlesNanomedicineOncology

Identifiers

PMID27547592
PMCPMC4991210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.